The SPHS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SPHS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SPHS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SPHS Detailed Price Forecast - CNN Money||View SPHS Detailed Summary - Google Finance|
|View SPHS Detailed Summary - Yahoo! Finance||View SPHS Stock Research & Analysis - Zacks.com|
|View SPHS Trends & Analysis - Trade-Ideas||View SPHS Major Holders - Barrons|
|View SPHS Call Transcripts - NASDAQ||View SPHS Breaking News & Analysis - Seeking Alpha|
|View SPHS Annual Report - CompanySpotlight.com||View SPHS OTC Short Report - OTCShortReport.com|
|View SPHS Fundamentals - TradeKing||View SPHS SEC Filings - Bar Chart|
|View Historical Prices for SPHS - The WSJ||View Performance/Total Return for SPHS - Morningstar|
|View the Analyst Estimates for SPHS - MarketWatch||View the Earnings History for SPHS - CNBC|
|View the SPHS Earnings - StockMarketWatch||View SPHS Buy or Sell Recommendations - MacroAxis|
|View the SPHS Bullish Patterns - American Bulls||View SPHS Short Pain Metrics - ShortPainBot.com|
|View SPHS Stock Mentions - StockTwits||View SPHS Stock Mentions - PennyStockTweets|
|View SPHS Stock Mentions - Twitter||View SPHS Investment Forum News - Investor Hub|
|View SPHS Stock Mentions - Yahoo! Message Board||View SPHS Stock Mentions - Seeking Alpha|
|View Insider Transactions for SPHS - SECform4.com||View Insider Transactions for SPHS - Insider Cow|
|View SPHS Major Holdings Summary - CNBC||View Insider Disclosure for SPHS - OTC Markets|
|View Insider Transactions for SPHS - Yahoo! Finance||View Institutional Holdings for SPHS - NASDAQ|
|View SPHS Stock Insight & Charts - FinViz.com||View SPHS Investment Charts - StockCharts.com|
|View SPHS Stock Overview & Charts - BarChart||View SPHS User Generated Charts - Trading View|
SPHS: Topline Results from Phase 2b Study of Topsalysin at end of 2Q18
Posted on Monday March 26, 2018
Sophiris Bio Inc. (SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign prostatic hyperplasia (BPH). The company’s lead candidate, topsalysin (PRX302), is a genetically engineered recombinant protein that is activated through enzymatic cleavage by prostate specific antigen (PSA), which is produced in large quantities by the prostate gland. Sophiris is currently conducting a Phase 2b clinical trial of topsalysin in patients with localized clinically significant prostate cancer (NCT03081481).
Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights
Posted on Wednesday March 21, 2018
SAN DIEGO and VANCOUVER, British Columbia , March 21, 2018 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin ...
Sophiris Bio to Present at 17th Annual Needham Healthcare Conference
Posted on Thursday March 15, 2018
SAN DIEGO and VANCOUVER, British Columbia , March 15, 2018 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin ...
Sophiris Bio to Participate in the 10th Annual Biotech Showcase Conference
Posted on Wednesday December 27, 2017
SAN DIEGO and VANCOUVER, British Columbia , Dec. 27, 2017 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin ...